Skip to content
10-Q

Quarterly Report

Celator Pharmaceuticals Inc

0001144204-15-064687

← back to feed
Filed
Nov 12, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2015 · Nov 11, 2015 34.55M sh
Capex Q3 2015 · Sep 30, 2015 $44.49K
Capex Q3 2015 · Sep 30, 2014 $14.46K
Long Term Debt Q3 2015 · Sep 30, 2015 $10.84M
Long Term Debt Q3 2015 · Dec 31, 2014 $9.84M
Short Term Debt Q3 2015 · Sep 30, 2015 $4.42M
Short Term Debt Q3 2015 · Dec 31, 2014 $284.96K
Cash And Equivalents Q3 2015 · Sep 30, 2015 $24.1M
Cash And Equivalents Q3 2015 · Dec 31, 2014 $32.41M
Cash And Equivalents Q3 2015 · Sep 30, 2014 $20.18M
Cash And Equivalents Q3 2015 · Dec 31, 2013 $23.59M
Stockholders Equity Q3 2015 · Sep 30, 2015 $8.66M
Stockholders Equity Q3 2015 · Dec 31, 2014 $21.91M
Current Liabilities Q3 2015 · Sep 30, 2015 $7.22M
Current Liabilities Q3 2015 · Dec 31, 2014 $3.29M
Total Liabilities Q3 2015 · Sep 30, 2015 $18.09M
Total Liabilities Q3 2015 · Dec 31, 2014 $13.21M
Current Assets Q3 2015 · Sep 30, 2015 $25.31M
Current Assets Q3 2015 · Dec 31, 2014 $33.57M
Total Assets Q3 2015 · Sep 30, 2015 $26.75M
Total Assets Q3 2015 · Dec 31, 2014 $35.12M
Sga Expense Q3 2015 · Sep 30, 2015 $1.94M
Sga Expense Q3 2015 · Sep 30, 2015 $5.72M
Sga Expense Q3 2015 · Sep 30, 2014 $1.87M
Sga Expense Q3 2015 · Sep 30, 2014 $5.49M
Rd Expense Q3 2015 · Sep 30, 2015 $2.86M
Rd Expense Q3 2015 · Sep 30, 2015 $9.02M
Rd Expense Q3 2015 · Sep 30, 2014 $3.33M
Rd Expense Q3 2015 · Sep 30, 2014 $9.24M
Net Income Q3 2015 · Sep 30, 2015 −$5.21M
Net Income Q3 2015 · Sep 30, 2015 −$14.9M
Net Income Q3 2015 · Sep 30, 2014 −$5.48M
Net Income Q3 2015 · Sep 30, 2014 −$14.55M
Operating Income Q3 2015 · Sep 30, 2015 −$4.72M
Operating Income Q3 2015 · Sep 30, 2015 −$13.58M
Operating Income Q3 2015 · Sep 30, 2014 −$5.12M
Operating Income Q3 2015 · Sep 30, 2014 −$13.97M